Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2003
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104194A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003032072A3 Crosslinkable monomers for novel nonlinear optical polymers
12/18/2003US20030232989 Process for the preparation of specific aromatic aldehydes
12/18/2003US20030232988 Methods for making bis-heterocyclic alkaloids
12/18/2003US20030232874 Methods and compositions for the treatment of chronic lymphocytic leukemia
12/18/2003US20030232873 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
12/18/2003US20030232872 Selective serotonin receptor antagonists and therapeutic applications thereof
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232843 (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232828 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/18/2003US20030232792 Useful for male contraception, treatment of a variety of hormone-related conditions such as sexual disorders, prostate cancer
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030232261 Linked dihydrazone-based charge transport compounds
12/18/2003CA2497609A1 Non-peptidic brs-3 agonists
12/18/2003CA2486581A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2485725A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370527A1 Indolone derivatives having vascular-damaging activity
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370525A1 Biguanide derivatives
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664291 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/16/2003US6664285 Use of cell membrane penetrating indigoid bisindole derivatives
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664025 Ethylenically unsaturated monomer capable of free radical addition polymerizatio catalysis; binder, photoinitiator and cyanopyidone sensitizer; metallocene and onium coninitiators
12/16/2003US6663847 Administering to mammal effective amount of cyanine dye for performing diagnostic or therapeutic procedure
12/16/2003CA2248407C Thermally stable aminosulfur trifluorides
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101966A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101961A1 Novel substituted indoles
12/11/2003WO2003101960A1 Processes for production of n-acylindolecarboxylic esters and indolecarboxylic acids
12/11/2003WO2003101944A1 Process for producing compound having biphenyl group substituted with lower alkylthio group
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003US20030229226 Cathepsin cysteine protease inhibitors
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/11/2003US20030228403 Catalytic hydrogenation; artificial sweetener
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003CA2487675A1 Novel substituted indoles
12/11/2003CA2487475A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/10/2003EP1369861A2 Optical recording media
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368027A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0882097B1 Compounds and method for synthesizing sulfoindocyanine dyes
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/10/2003CN1130343C Process for synthesis of indolyl-3-acetamides
12/09/2003US6660763 Bis-indolylquinone compounds
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099814A1 Calcium receptor modulating agents
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 458